76 related articles for article (PubMed ID: 8476882)
1. Laboratory-clinical correlates of time-associated lesions in the vascular immunopathology of human cardiac allografts.
Faulk WP; Labarrere CA; Pitts D; Halbrook H
J Heart Lung Transplant; 1993; 12(2):S125-34. PubMed ID: 8476882
[TBL] [Abstract][Full Text] [Related]
2. Vascular lesions in biopsy specimens devoid of cellular infiltrates: qualitative and quantitative immunocytochemical studies of human cardiac allografts.
Faulk WP; Labarrere CA; Pitts D; Halbrook H
J Heart Lung Transplant; 1993; 12(2):219-29. PubMed ID: 8476894
[TBL] [Abstract][Full Text] [Related]
3. Tissue plasminogen activator, plasminogen activator inhibitor-1, and fibrin as indexes of clinical course in cardiac allograft recipients. An immunocytochemical study.
Labarrere CA; Pitts D; Halbrook H; Faulk WP
Circulation; 1994 Apr; 89(4):1599-608. PubMed ID: 8149527
[TBL] [Abstract][Full Text] [Related]
4. Vascular immunopathology and atheroma development in human allografted organs.
Faulk WP; Labarrere CA
Arch Pathol Lab Med; 1992 Dec; 116(12):1337-44. PubMed ID: 1456881
[TBL] [Abstract][Full Text] [Related]
5. Immunoglobulin M antibodies in transplanted human hearts.
Labarrere CA; Pitts D; Halbrook H; Faulk WP
J Heart Lung Transplant; 1993; 12(3):394-402. PubMed ID: 8329409
[TBL] [Abstract][Full Text] [Related]
6. Vascular abnormalities and cardiomyocyte lipofuscin deposits in endomyocardial biopsy specimens of heart transplant recipients: are they related to the development of cardiac allograft vasculopathy?
Zakliczynski M; Nozynski J; Konecka-Mrowka D; Krynicka-Mazurek A; Swierad M; Maruszewski M; Przybylski R; Zembala M
J Thorac Cardiovasc Surg; 2009 Jul; 138(1):215-21, 221.e1-3. PubMed ID: 19577082
[TBL] [Abstract][Full Text] [Related]
7. Vascular (humoral) rejection in heart transplantation: pathologic observations and clinical implications.
Hammond EH; Yowell RL; Nunoda S; Menlove RL; Renlund DG; Bristow MR; Gay WA; Jones KW; O'Connell JB
J Heart Transplant; 1989; 8(6):430-43. PubMed ID: 2693662
[TBL] [Abstract][Full Text] [Related]
8. Vascular events in placentae and organ allografts.
Faulk WP; Labarrere CA
Am J Reprod Immunol; 1992; 28(3-4):176-80. PubMed ID: 1285873
[TBL] [Abstract][Full Text] [Related]
9. Expression patterns of vascular endothelial growth factor in human cardiac allografts: association with rejection.
Reinders ME; Fang JC; Wong W; Ganz P; Briscoe DM
Transplantation; 2003 Jul; 76(1):224-30. PubMed ID: 12865814
[TBL] [Abstract][Full Text] [Related]
10. Quantitation of cytomegalovirus infection-associated histologic findings in endomyocardial biopsies of heart allografts.
Koskinen PK; Krogerus LA; Nieminen MS; Mattila SP; Häyry PJ; Lautenschlager IT
J Heart Lung Transplant; 1993; 12(3):343-54. PubMed ID: 8392371
[TBL] [Abstract][Full Text] [Related]
11. Temporal reduction in acute rejection after heart transplantation is not associated with a reduction in cell-mediated responses to donor-specific vascular endothelium.
Hosenpud JD; Shipley GD; Mauck KA; Morris TE; Wagner CR
J Heart Lung Transplant; 1995; 14(5):926-37. PubMed ID: 8800729
[TBL] [Abstract][Full Text] [Related]
12. Role of the antibody to vascular endothelial cells in hyperacute rejection in patients undergoing cardiac transplantation.
Trento A; Hardesty RL; Griffith BP; Zerbe T; Kormos RL; Bahnson HT
J Thorac Cardiovasc Surg; 1988 Jan; 95(1):37-41. PubMed ID: 2447445
[TBL] [Abstract][Full Text] [Related]
13. Additive value of immunologic monitoring to histologic grading of heart allograft biopsy specimens: implications for therapy.
Fisher PE; Suciu-Foca N; Ho E; Michler RE; Rose EA; Mancini D
J Heart Lung Transplant; 1995; 14(6 Pt 1):1156-61. PubMed ID: 8719463
[TBL] [Abstract][Full Text] [Related]
14. Vascular rejection in heart transplantation: clinical correlation, treatment options, and future considerations.
Olsen SL; Wagoner LE; Hammond EH; Taylor DO; Yowell RL; Ensley RD; Bristow MR; O'Connell JB; Renlund DG
J Heart Lung Transplant; 1993; 12(2):S135-42. PubMed ID: 8476883
[TBL] [Abstract][Full Text] [Related]
15. Vascular tissue plasminogen activator and the development of coronary artery disease in heart-transplant recipients.
Labarrere CA; Pitts D; Nelson DR; Faulk WP
N Engl J Med; 1995 Oct; 333(17):1111-6. PubMed ID: 7565949
[TBL] [Abstract][Full Text] [Related]
16. Complement contributes to the rejection of complete and class I major histocompatibility complex--incompatible cardiac allografts.
Qian Z; Jakobs FM; Pfaff-Amesse T; Sanfilippo F; Baldwin WM
J Heart Lung Transplant; 1998 May; 17(5):470-8. PubMed ID: 9628565
[TBL] [Abstract][Full Text] [Related]
17. Peritubular capillary C4d staining in late acute renal allograft rejection--is it relevant?
Satoskar AA; Lehman AM; Nadasdy GM; Sedmak DD; Pesavento TE; Henry ML; Pelletier RP; Ferguson RM; Nadasdy T
Clin Transplant; 2008; 22(1):61-7. PubMed ID: 18217907
[TBL] [Abstract][Full Text] [Related]
18. Utility of posttransplantation panel-reactive antibody measurements for the prediction of rejection frequency and survival of heart transplant recipients.
George JF; Kirklin JK; Shroyer TW; Naftel DC; Bourge RC; McGiffin DC; White-Williams C; Noreuil T
J Heart Lung Transplant; 1995; 14(5):856-64. PubMed ID: 8800720
[TBL] [Abstract][Full Text] [Related]
19. Accommodated xenografts survive in the presence of anti-donor antibodies and complement that precipitate rejection of naive xenografts.
Lin Y; Soares MP; Sato K; Takigami K; Csizmadia E; Smith N; Bach FH
J Immunol; 1999 Sep; 163(5):2850-7. PubMed ID: 10453031
[TBL] [Abstract][Full Text] [Related]
20. The relationship of nodular endocardial infiltrates (Quilty lesions) to survival, patient age, anti-HLA antibodies, and coronary artery disease following heart transplantation.
Chu KE; Ho EK; de la Torre L; Vasilescu ER; Marboe CC
Cardiovasc Pathol; 2005; 14(4):219-24. PubMed ID: 16009321
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
